SCHEMBL3526329

SCHEMBL3526329

NCC=Cc1ccc(O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.54
MAOB P27338 3/20 0.48
AKR1B1 P15121 3/20 0.48
PTGS2 P35354 2/20 0.48
AKR1B10 O60218 2/20 0.48
GLO1 Q04760 1/20 0.48
CAMK2A Q9UQM7 1/20 0.48
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 3/20 0.48
MAPT P10636 3/20 0.48
CYP2C9 P11712 3/20 0.48
CA12 O43570 3/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA3 P07451 3/20 0.48
CA4 P22748 3/20 0.48
CA6 P23280 3/20 0.48
CA5A P35218 3/20 0.48
CA7 P43166 3/20 0.48
CA9 Q16790 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10421204 1.00 APP (0.54) APPMAOBAKR1B1PTGS2AKR1B10
Hydrochloric Acid SCHEMBL11478395 0.98 APP (0.52) APPMAOBAKR1B1PTGS2AKR1B10
Hydrochloric Acid SCHEMBL11478399 0.98 APP (0.52) APPMAOBAKR1B1PTGS2AKR1B10
SCHEMBL23728175 0.82 APP (0.59) APPMAOBAKR1B1PTGS2AKR1B10
Paraben SCHEMBL3840484 0.78 KMT2A (0.54) MAOBMAPTCA12CA1CA2
SCHEMBL221967 0.78 ALDH1A1 (0.59) APPMAOBAKR1B1PTGS2AKR1B10
SCHEMBL31289417 0.78 APP (0.54) APPMAOBAKR1B1PTGS2AKR1B10
SCHEMBL8527959 0.78 APP (0.54) APPMAOBALDH1A1MAPTMEN1
SCHEMBL221968 0.78 ALDH1A1 (0.59) APPMAOBAKR1B1PTGS2AKR1B10
SCHEMBL12426096 0.78 APP (0.54) APPMAOBALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040112470-A1 High performance non-chrome pretreatment for can-end stock aluminum HENKEL AG & CO. KGAA (DE) 2004-06-17 US claimed
EP-0728225-A4 1996-09-11 EP claimed
EP-0728225-A1 COMPOSITION AND PROCESS FOR TREATING METAL HENKEL CORPORATION (US) 1996-08-28 EP claimed
WO-1995009934-A1 COMPOSITION AND PROCESS FOR TREATING METAL HENKEL CORPORATION (US) 1995-04-13 WO claimed
EP-0633951-A1 COMPOSITION AND PROCESS FOR TREATING METAL. HENKEL CORP (US) 1995-01-18 EP claimed
WO-1993020260-A1 COMPOSITION AND PROCESS FOR TREATING METAL HENKEL CORPORATION (US) 1993-10-14 WO claimed
EP-2913325-B1 SUBSTITUTED PYRIMIDINE COMPOUND AND USES THEREOF SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD (CN) 2021-04-21 EP disclosed
EP-3760617-A1 SUBSTITUTED PYRIMIDINE COMPOUND AND USES THEREOF Shenyang Sinochem Agrochemicals R&D Co., Ltd. (CN) 2021-01-06 EP disclosed
US-9770026-B2 Substituted pyrimidine compound and uses thereof SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) 2017-09-26 US disclosed
EP-2228362-B1 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE DOW CORNING TORAY CO LTD (JP) 2017-06-07 EP disclosed
US-20150257385-A1 Substituted Pyrimidine Compound and Uses Thereof SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) 2015-09-17 US disclosed
EP-2913325-A1 SUBSTITUTED PYRIMIDINE COMPOUND AND USES THEREOF Sinochem Corporation (CN) 2015-09-02 EP disclosed
CN-101903332-B 4-hydroxyphenylalkylamine derivative DOW CORNING TORAY CO LTD 2015-01-14 CN disclosed
US-5009981-A Polymerizable photosensitive diazo compound, polymeric binder, photoinitiator KONICA CORPORATION (JP) 1991-04-23 US disclosed
EP-0385952-A2 Use of a naphthalenmethanamino derivative as antiinflammatory agent and pharmaceutical compositions containing it SANDOZ AG (CH) 1990-09-05 EP disclosed
US-4933325-A ANALGESICS, HYPOTENSIVE AGENTS G. D. SEARLE & CO. (US) 1990-06-12 US disclosed
US-4880829-A ANALGESICS, HYPOTENSIVE AGENTS G. D. SEARLE AND COMPANY (US) 1989-11-14 US disclosed
US-4847241-A ANALGESICS G. D. SEARLE & CO. (US) 1989-07-11 US disclosed
US-4822775-A ANALGESICS G. D. SEARLE & CO. (US) 1989-04-18 US disclosed
EP-0215297-A2 Substituted dipeptide amides G.D. Searle & Co. (US) 1987-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150257385-A1 Substituted Pyrimidine Compound and Uses Thereof TYR, GART, LRRK2 APP 243/4885MAOB 87/4885AKR1B1 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.